Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

SK Bioscience302440

SK Bioscience (302440) Preliminary Earnings, Nov 5, 2026

Filing date ·

SK Bioscience reported preliminary Q3 2026 results (consolidated): Revenue of KRW 182.4 billion (+21.0% year over year), operating profit of -KRW 11.2 billion,…

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.